Animal carcinogenicity studies: implications for the REACH system

Area of Science:

• Toxicology
• Chemical Safety Assessment
• Regulatory Science

Background:

• The Registration, Evaluation and Authorisation of Chemicals (REACH) aims to protect health by assessing chemical toxicity.
• Accurate identification of chemical carcinogens is crucial for REACH, with cancer incidence reduction as a key expected benefit.
• Current reliance on animal testing for carcinogen identification faces limitations due to data variability and extrapolation challenges.

Purpose of the Study:

• To evaluate the adequacy of animal carcinogenicity data for classifying chemical risks to humans.
• To propose alternative methods for more accurate human carcinogenicity prediction within regulatory frameworks like REACH.
• To highlight the limitations of animal models in predicting human carcinogenic potential.

Main Methods:

• Surveyed the US Environmental Protection Agency's (EPA) toxic chemicals database for carcinogenicity data adequacy.
• Analyzed the variety of species, administration routes, and affected organ systems in animal carcinogenicity studies.
• Compared EPA assessments with International Agency for Research on Cancer (IARC) evaluations for identical chemicals.

Main Results:

• Animal carcinogenicity data was inadequate for classifying 58.1% (93/160) of chemicals of high public health concern.
• Significant biological variability in animal models complicates accurate extrapolation of findings to humans.
• Discrepancies in IARC assessments of identical chemicals suggest poor predictive accuracy of animal data.

Conclusions:

• Animal carcinogenicity bioassays are insufficient for reliable human risk assessment.
• A tiered approach using non-animal assays can provide superior human predictivity for carcinogenic risk.
• Alternative methods offer resource savings and enhanced understanding of carcinogenicity mechanisms.